Literature DB >> 3384541

The mortality of hospital-acquired bloodstream infections: need for a new vital statistic?

R P Wenzel1.   

Abstract

Available data on both crude mortality and attributable mortality of hospital-acquired bloodstream infections suggest that such infections represent an important cause of death in the US. The use of 95% confidence limits for attributable mortality and current national vital statistics data for septicaemia corroborate the general hypothesis.

Entities:  

Mesh:

Year:  1988        PMID: 3384541     DOI: 10.1093/ije/17.1.225

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  17 in total

1.  Premature birth and the changing composition of newborn infectious disease mortality: reconsidering "exogenous" mortality.

Authors:  K A Sowards
Journal:  Demography       Date:  1997-08

2.  Regulatory effect of histamine on the barrier function of intestinal mucosal.

Authors:  Ligeng Duan; Xiaoli Chen; J W Alexander
Journal:  J Gastrointest Surg       Date:  2010-04-30       Impact factor: 3.452

3.  Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.

Authors:  S Stöve; T Welte; T O Wagner; A Kola; A Klos; W Bautsch; J Köhl
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

4.  Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.

Authors:  B N Doebbeling; M A Pfaller; M J Bale; R P Wenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

Review 5.  Epidemiology, therapy and costs of nosocomial infection.

Authors:  R Gálvez-Vargas; A Bueno-Cavanillas; M García-Martín
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

6.  Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study.

Authors:  Stijn Blot; Koenraad Vandewoude; Francis Colardyn
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

7.  Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; M Poppelier; K Kraaijeveld; J Verhoef
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  Long term trends in the occurrence of nosocomial blood stream infection.

Authors:  G Taylor; M Buchanan-Chell; T Kirkland; M McKenzie; R Wiens
Journal:  Can J Infect Dis       Date:  2000-01

9.  Reduction of lipopolysaccharide-induced cyclooxygenase-2 expression in diabetic arteries.

Authors:  Yuji Takahashi; Michael Poteser; Munetaka Negoro; Ichiro Wakabayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-20       Impact factor: 3.000

Review 10.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.